Could a diabetes drug curb alcohol cravings after bariatric surgery?
NCT ID NCT07223983
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study at Yale tests whether semaglutide (a drug used for diabetes and weight loss) can help people who have had bariatric surgery and now struggle with alcohol use disorder. Ten adults will take the drug for three months and be followed for three more months to see if it reduces drinking and helps maintain weight loss. The goal is to see if this approach is feasible and worth studying in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale School of Medicine
RECRUITINGNew Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smartphone support for sobriety: a trial tests digital tools in black communities
- Can popular Weight-Loss drugs alter breastmilk supply?
- Diaper duty gets smart: a changing pad that tracks Baby's weight, feeding, and sleep
- Can alternating feast and fast days beat daily dieting for lasting weight loss?
- Emergency room could be the starting point for alcohol addiction treatment
- Could a diabetes drug protect obese Teens' hearts?